Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$4.93 - $9.31 $20,213 - $38,171
-4,100 Reduced 19.52%
16,900 $84,000
Q4 2023

Feb 14, 2024

BUY
$7.13 - $9.49 $149,730 - $199,290
21,000 New
21,000 $188,000
Q4 2022

Feb 14, 2023

SELL
$4.11 - $8.14 $111,792 - $221,408
-27,200 Reduced 63.26%
15,800 $68,000
Q3 2022

Nov 14, 2022

BUY
$6.66 - $12.39 $155,844 - $289,926
23,400 Added 119.39%
43,000 $323,000
Q2 2022

Aug 08, 2022

BUY
$8.95 - $12.8 $167,365 - $239,360
18,700 Added 2077.78%
19,600 $197,000
Q4 2021

Feb 14, 2022

SELL
$17.78 - $33.08 $56,896 - $105,856
-3,200 Reduced 78.05%
900 $21,000
Q3 2021

Nov 15, 2021

SELL
$10.93 - $23.55 $91,812 - $197,820
-8,400 Reduced 67.2%
4,100 $91,000
Q2 2021

Aug 16, 2021

SELL
$10.0 - $14.52 $103,000 - $149,556
-10,300 Reduced 45.18%
12,500 $162,000
Q1 2021

May 17, 2021

BUY
$12.3 - $18.73 $280,440 - $427,044
22,800 New
22,800 $296,000
Q3 2020

Nov 16, 2020

SELL
$13.19 - $16.66 $6,595 - $8,330
-500 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$14.12 - $18.33 $96,016 - $124,643
-6,800 Reduced 93.15%
500 $8,000
Q1 2020

May 15, 2020

SELL
$11.34 - $21.46 $720,090 - $1.36 Million
-63,500 Reduced 89.69%
7,300 $106,000
Q4 2019

Feb 14, 2020

BUY
$3.88 - $21.42 $263,452 - $1.45 Million
67,900 Added 2341.38%
70,800 $1.43 Million
Q2 2019

Aug 14, 2019

SELL
$6.05 - $6.75 $43,560 - $48,600
-7,200 Reduced 71.29%
2,900 $19,000
Q1 2019

May 15, 2019

BUY
$6.06 - $7.64 $61,205 - $77,164
10,100 New
10,100 $66,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.14B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.